Evidence map›Paper›PMID 19533253›Full record

ArticleIn vitro cellular & developmental biology. Animal2009

Generation of a tumor spheroid in a microgravity environment as a 3D model of melanoma.

Bernadette Marrero, Jane L Messina, Richard Heller

Abstract read
In one paragraph

Article in In vitro cellular & developmental biology. Animal, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Cancer research by means of tissue engineering--is there a rationale?Journal of cellular and molecular medicine · 2013
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bernadette MarreroDepartment of Molecular Medicine, University of South Florida, Tampa, FL 33612, USA.
Jane L Messina
Richard Heller

Funding

Therapeutic Potential of IL-15 Plasmid Delivery to Tumors Using ElectroporationR01CA122518 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI HELLER, RICHARD · 2008 to 2013
$1.6M
An Anti-tumor Therapy Utilizing EP to Deliver IL-15 into B16.F10 MelanomaF31CA119950 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI MARRERO, BERNADETTE · 2007 to 2010
$97k
NCI NIH HHS 1F31CA119950-01A2NCI NIH HHS F31 CA119950NCI NIH HHS R01 CA122518
6 · The paper itself

Abstract

An in vitro 3D model was developed utilizing a synthetic microgravity environment to facilitate studying the cell interactions. 2D monolayer cell culture models have been successfully used to understand various cellular reactions that occur in vivo. There are some limitations to the 2D model that are apparent when compared to cells grown in a 3D matrix. For example, some proteins that are not expressed in a 2D model are found up-regulated in the 3D matrix. In this paper, we discuss techniques used to develop the first known large, free-floating 3D tissue model used to establish tumor spheroids. The bioreactor system known as the High Aspect Ratio Vessel (HARVs) was used to provide a microgravity environment. The HARVs promoted aggregation of keratinocytes (HaCaT) that formed a construct that served as scaffolding for the growth of mouse melanoma. Although there is an emphasis on building a 3D model with the proper extracellular matrix and stroma, we were able to develop a model that excluded the use of matrigel. Immunohistochemistry and apoptosis assays provided evidence that this 3D model supports B16.F10 cell growth, proliferation, and synthesis of extracellular matrix. Immunofluorescence showed that melanoma cells interact with one another displaying observable cellular morphological changes. The goal of engineering a 3D tissue model is to collect new information about cancer development and develop new potential treatment regimens that can be translated to in vivo models while reducing the use of laboratory animals.

Indexed as

Models, BiologicalWeightlessnessAnimalsCell Culture TechniquesCell MovementCell ProliferationCell SurvivalExtracellular MatrixFluorescent Antibody TechniqueHumansMelanomaMiceSpheroids, CellularTumor Cells, Cultured

Identifiers

PMID19533253
PMCPMC3138212

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.